Lung clearance index: Evidence for use in clinical trials in cystic fibrosis von Kent, L, Reix, P, Innes, J.A, Zielen, S, Le Bourgeois, M, Braggion, C, Lever, S, Arets, H.G.M, Brownlee, K, Bradley, J.M, Bayfield, K, O'Neill, K, Savi, D, Bilton, D, Lindblad, A, Davies, J.C, Sermet, I, De Boeck, K

Volltext

133 Multiple breath washout (MBW) testing: experiences from a training programme von O'Neill, K, Bradley, J.M, Rowan, S, Elborn, J.S

Volltext

Analysis of Seroreactivity against Cell Culture–Derived Bartonella spp. Antigens in Dogs von Hegarty, B.C, Bradley, J.M, Lappin, M.R, Balakrishnan, N, Mascarelli, P.E, Breitschwerdt, E.B

Volltext

229 Using theory to design a physical activity behaviour change intervention: An evidence synthesis of barriers, enablers and pathways of change in CF von Kent, L, Bradley, J.M

Volltext

Airway clearance techniques used by people with cystic fibrosis in the UK von Hoo, Z.H, Daniels, T, Wildman, M.J, Teare, M.D, Bradley, J.M

Volltext

140 An evaluation of cystic fibrosis (CF)-related complications and treatment in patients (pts) with CF and at least one copy of the R117H (c.350G>A) mutation in the UK and the US von Addy, C, O'Sullivan, A.K, Fridman, M, Bradley, J.M, Elborn, J.S, Downey, D.G

Volltext

139 Disease burden in patients (pts) with cystic fibrosis (CF) with at least one copy of the R117H (c.350G>A) mutation in the UK von Addy, C, O'Sullivan, A.K, Fridman, M, Bradley, J.M, Elborn, J.S, Downey, D.G

Volltext

151 Mannitol dry powder inhalation for cystic fibrosis: evaluation of implementation into clinical practice von Cosgrove, D, Bradley, J.M, Lavery, K, Mills, V, McClenaghan, V, Loughran, C, Rendall, J

Volltext

Demographic and Historical Findings, Including Exposure to Environmental Tobacco Smoke, in Dogs with Chronic Cough von Hawkins, E.C, Clay, L.D, Bradley, J.M, Davidian, M

Volltext

288 Airway clearance techniques used by people with cystic fibrosis in the UK von Hoo, Z.H, Daniels, T, Wildman, M, Teare, M.D, Bradley, J.M

Volltext

129 Shortened SF6 MBW is a repeatable and sensitive test in adults and children with CF von Hannon, D, Bradbury, I, Bradley, J.M, Reid, A, Bell, N.J, Elborn, J.S, O'Neill, K

Volltext

WS14.6 Feasibility study to objectively measure airway clearance technique in cystic fibrosis von Hoo, Z.H, Daniels, T, Bradley, J.M, Heller, B, Rose, C, Wildman, M

Volltext

WS20.5 A high colony count of anaerobic bacteria is related to lung clearance index in cystic fibrosis von O'Neill, K, Johnston, E, McGrath, S.J, McIlreavey, L, Bradley, J.M, Rowan, S, Reid, A, Bradbury, I, Tunney, M, Elborn, J.S

Volltext

WS7.3 Relationships between lung clearance index (LCI), patient reported symptoms and health related quality of life (HRQoL) in CF von O'Neill, K, Johnston, E, Tunney, M, Elborn, J.S, Bradley, J.M

Volltext

159 Lung Clearance Index (LCI) during and following a pulmonary exacerbation (PEx) in patients with CF von O'Neill, K, Johnston, E, Tunney, M, Elborn, J.S, Bradley, J.M

Volltext

WS13.2 Lung clearance index (LCI) and airway infection in CF von O'Neill, K, Bradley, J.M, Johnston, E, Reid, A, McCaughan, J, Moore, J.E, Tunney, M, Elborn, J.S

Volltext

“Copying letters” to CF patients: patient perceptions of benefit von Treacy, K, Elborn, J.S, Rendall, J, Bradley, J.M

Volltext

P247 Use of the Fitbit Charge HR to monitor physical activity, sleep and heart rate during IV therapy for pulmonary exacerbations von Addy, C., Bradley, J.M., Elborn, J.S., Downey, D.G.

Volltext

142 Frequency of sputum sampling in an adult CF outpatient clinic:How much is too much? von Boyle, L.R, Stronge, D.E, Bradley, J.M, Elborn, J.S

Volltext

143 Does increased frequency of sputum sampling alter antibiotic choice during exacerbations? von Boyle, L.R, Stronge, D.E, Bradley, J.M, Elborn, J.S

Volltext